EcoDrugPlus

Ensembl ID : ENSGACG00000007500
Gene Symbol: -
Cross references: -
138 Possible Orthologues:

Ensembl ID : ENSGACG00000007507
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSGACG00000016632
Gene Symbol: -
Cross references: -
225 Possible Orthologues:

Ensembl ID : ENSGACG00000006730
Gene Symbol: TIE1
1 Cross references
207 Possible Orthologues:

Ensembl ID : ENSGACG00000018189
Gene Symbol: RXRAA
1 Cross references
231 Possible Orthologues:

Ensembl ID : ENSGACG00000006102
Gene Symbol: -
Cross references: -
162 Possible Orthologues:

Ensembl ID : ENSGACG00000000237
Gene Symbol: -
Cross references: -
176 Possible Orthologues:

Ensembl ID : ENSGACG00000008157
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSGACG00000019181
Gene Symbol: RPS15A
1 Cross references
566 Possible Orthologues:

Ensembl ID : ENSGACG00000008449
Gene Symbol: -
1 Cross references
218 Possible Orthologues:

Ensembl ID : ENSGACG00000020741
Gene Symbol: -
Cross references: -
132 Possible Orthologues:

Ensembl ID : ENSGACG00000003250
Gene Symbol: RPL24
1 Cross references
318 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).